Nebraska's Morning News

Nebraska's Morning News

Join Scott Voorhees, Jim Rose, Lucy Chapman, Craig Evans and the rest of the Nebraska's Morning News team weekdays from 6-9am for news, weather, traffic, sports, and the conversations that connect us

 

FDA Approves "Promising" Treatment for Multiple Sclerosis

The FDA has approved the drug, Ocrevus, for treatment of multiple sclerosis.  While the drug is promising, it does have some potential side effects.  Dr. Rana Zabad told us more about Ocrevus and the promise that it may hold for M.S. patients.  Here's is a link to a story about Ocrevus.


Sponsored Content

Sponsored Content